MRC1 and central nervous system neoplasm: Similarly, Gylling et al. [28] showed that FLA was unable to detect increased MSI in CNS tumours from LS gene carriers, whilst small pool PCR-based MSI analysis and IHC showed the tumours to be MMR deficient.